Relmada Therapeutics (RLMD) Interest Coverage Ratio (2014 - 2015)
Relmada Therapeutics (RLMD) reported Interest Coverage Ratio of 4882.52 for Q4 2015, down 22.26% year-over-year from 6280.67 in Q4 2014, and down 73.17% quarter-over-quarter from 2819.49 in Q3 2015.
Relmada Therapeutics (RLMD) Interest Coverage Ratio (2014 - 2015) Analysis & Trends
Relmada Therapeutics (RLMD) has 2 years of Interest Coverage Ratio data on file, last reported at 4882.52 in Q4 2015.
- Interest Coverage Ratio for Q4 2015 came in at 4882.52, down 22.26% year-over-year; the trailing twelve-month figure through Sep 2016 was 11252.96 (down 106.1% YoY), and the FY2015 annual result was 3474.05, changed N/A from the prior year.
- Interest Coverage Ratio slipped to 4882.52 in Q4 2015 per RLMD's latest filing, from 2819.49 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 5.75 in Q1 2014 and troughed at 36626.46 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Relmada Therapeutics | 581.07 Mn | 581.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -4,882.52 |
| Sep 30, 2015 | -2,819.49 |
| Jun 30, 2015 | -10,215.86 |
| Mar 31, 2015 | -36,626.46 |
| Dec 31, 2014 | -3,993.52 |
| Sep 30, 2014 | -1,139.10 |
| Jun 30, 2014 | -29.72 |
| Mar 31, 2014 | -5.75 |